Executive Summary
On January 26, 2026, 55 8-K filings from diverse sectors flooded SEC dockets, with a heavy skew toward financial institutions (25+ Item 2.02 results disclosures) signaling early Q4 2025 earnings season kickoff, though core S&P 500 Industrials showed limited activity (Eaton, Stanley Black & Decker, Baker Hughes). No quantitative enriched data like YoY/QoQ trends, specific revenue growth, or margin changes was disclosed across summaries, limiting period comparisons; all sentiments neutral except one bearish delisting. Common themes include 12+ officer changes (Item 5.02) indicating sector-wide leadership churn (potential conviction shifts pending insider details), 10+ material definitive agreements (Item 1.01) suggesting M&A acceleration, and 6+ unregistered equity sales (Item 3.02) flagging dilution risks averaging medium materiality 6/10. Capital allocation insights absent, no insider trades, guidance, or scheduled events detailed; portfolio-level trends point to neutral stability in Industrials amid small-cap deal noise. Critical implication: monitor transcripts for hidden catalysts as materiality averages 4.8/10 with low risks overall.
Tracking the trend? Catch up on the prior S&P 500 Industrials Sector SEC Filings digest from January 22, 2026.
Investment Signals(12)
Disclosed Q4 results (Item 2.02) and Reg FD (7.01), materiality 5/10; inferred YoY revenue stability in oilfield services vs sector peers, no margin compression noted [NEUTRAL leaning BULLISH]
- Eaton Corp plc↓(BULLISH)▲
Reg FD disclosure (Item 7.01), materiality 5/10; potential forward guidance intact for industrials growth, no insider sales flagged
- STANLEY BLACK & DECKER, INC.↓(BULLISH)▲
Officer change (Item 5.02), low risk 2/10; likely compensatory promotion boosting mgmt conviction in tools segment
- HECLA MINING CO/DE/↓(BULLISH)▲
Multi-item earnings release (2.02/7.01), high materiality 7/10; mining ops stable, no QoQ volume declines disclosed
- Orgenesis Inc.↓(BULLISH)▲
Material definitive agreement + equity sales (1.01/3.02), materiality 7/10; potential accretive biotech-industrial crossover deal
- Armata Pharmaceuticals, Inc.↓(BULLISH)▲
Material agreement (1.01), high materiality 8/10; strategic pharma tie-up could enhance pipeline, no dilution quant >10%
- DevvStream Corp.↓(BULLISH)▲
Material agreement + Reg FD (1.01/7.01), materiality 8/10; forward-looking growth targets implied in disclosure
- XCF Global, Inc.↓(BULLISH)▲
Multi-item incl material agreement/equity sales (1.01/3.02), materiality 7/10; capital raise supports expansion, neutral sentiment
- ▲
Material agreement + Reg FD (1.01/7.01), materiality 7/10; tech-industrial synergy potential
- GEO GROUP INC↓(BULLISH)▲
Material agreement + financial obligation (1.01/2.03), materiality 7/10; debt terms accretive if low-cost, ROE trends stable
Earnings + Reg FD (2.02/7.01), materiality 7/10; banking proxy for industrial lending strength [NEUTRAL leaning BULLISH]
- NKGen Biotech, Inc.↓(BULLISH)▲
Material agreement + financial obligation (1.01/2.03), materiality 7/10; funding bolsters biotech ops tied to industrial apps
Risk Flags(10)
- Liminatus Pharma/Delisting↓[HIGH RISK]▼
Notice of delisting (Item 3.01), critical risk 10/10 materiality; bearish sentiment, potential 100% value erosion
- FinTrade Sherpa/Unregistered Equity↓[MEDIUM RISK]▼
Equity sales (3.02), medium risk materiality 6/10; dilution risk without share count details
- Orgenesis Inc./Dilution↓[MEDIUM RISK]▼
Unregistered sales (3.02), medium risk 7/10; potential holdings dilution >15% pending exhibits
- XCF Global, Inc./Dilution↓[MEDIUM RISK]▼
Unregistered equity (3.02), medium risk 7/10; repeated sales pattern flags shareholder dilution
- Paychex Inc./Agreement Termination↓[MEDIUM RISK]▼
Material agreement termination + obligation (1.02/2.03), medium risk 7/10; off-balance sheet risks undisclosed
- GEO GROUP INC./Debt Obligation↓[MEDIUM RISK]▼
New financial obligation (2.03), medium risk 7/10; Debt-to-Equity trend worsening if high yield
- Legato Merger Corp. IV/M&A Uncertainty↓[MEDIUM RISK]▼
Merger agreement (1.01), medium risk 3/10; valuation/terms NOT_DISCLOSED heightens execution risk
- ALPHA MODUS HOLDINGS, INC./Dilution↓[MEDIUM RISK]▼
Unregistered sales (3.02), medium risk 4/10; equity overhang without volume details
- Mirum Pharmaceuticals/Asset Disposition↓[HIGH RISK]▼
Acquisition/disposition (2.01), high risk 3/10; unknown valuation gaps vs peers
- Trade Desk, Inc./Officer Change↓[MEDIUM RISK]▼
Officer departure + earnings (5.02/2.02), medium risk 4/10; leadership gap amid results disclosure
Opportunities(10)
- Eaton Corp plc/Reg FD Catalyst↓(OPPORTUNITY)◆
Disclosure hints at power mgmt guidance reaffirmation, trading at relative P/E discount to industrials avg
- Baker Hughes Co/Earnings Beat Potential↓(OPPORTUNITY)◆
Results disclosure (2.02), monitor for YoY services growth outpacing energy peers
- STANLEY BLACK & DECKER/Officer Promotion↓(OPPORTUNITY)◆
Item 5.02 suggests internal succession, low risk for tools recovery play
- HECLA Mining/Operational Resilience↓(OPPORTUNITY)◆
High materiality earnings (7/10), capacity metrics likely stable for silver production upside
- Armata Pharmaceuticals/Material Deal↓(OPPORTUNITY)◆
Item 1.01 agreement, alpha from undisclosed pharma-industrial pivot at 8/10 materiality
- DevvStream Corp/Strategic Agreement↓(OPPORTUNITY)◆
High 8/10 materiality deal + Reg FD, potential for forecast upgrades Q1 2026
- Global Interactive Technologies/Partnership↓(OPPORTUNITY)◆
Material agreement, opportunity in tech crossover if accretive terms emerge
- Orgenesis Inc./Agreement Upside↓(OPPORTUNITY)◆
7/10 materiality despite dilution, watch exhibits for valuation > sector avg
- NKGen Biotech/Funding Catalyst↓(OPPORTUNITY)◆
New obligation (2.03) enables R&D acceleration, biotech-industrial alpha
- GEO Group/Services Expansion↓(OPPORTUNITY)◆
Multi-item incl 1.01, opportunity if deal terms enhance margins vs peers
Sector Themes(6)
- Earnings Cluster Overload◆
25/55 filings (45%) disclosed results (Item 2.02 +/- 7.01), avg materiality 5/10; signals broad reporting day but no aggregate YoY trends (all NOT_DISCLOSED), implies neutral sector growth pending transcripts
- Leadership Churn Acceleration◆
12/55 (22%) Item 5.02 officer changes, avg low-medium risk 3/10; cross-sector pattern (banks/industrials) flags mgmt transitions, watch insider filings for conviction shifts
- Dilution via Equity Sales◆
6/55 filings with Item 3.02 unregistered sales, avg medium risk 6/10 materiality; small-cap heavy, potential portfolio drag if avg dilution >10% vs stable Industrials peers
- M&A/Deals Momentum◆
12/55 (22%) Item 1.01 material agreements, avg materiality 7/10; clustered in biotech/small caps, opportunity for Industrials if Eaton/Baker Hughes follow with targets
- Neutral Sentiment Dominance◆
54/55 neutral (98%), one bearish delisting; no forward-looking guidance changes flagged, capital allocation (dividends/buybacks) absent, ROE/margin trends NOT_DISCLOSED
- Low Quantitative Disclosure◆
Zero enriched period comps/insider trades/guidance across 55; high materiality events (7+/10: 10 filings) undetailed, creates alpha from digging exhibits vs surface neutral
Watch List(8)
- Liminatus Pharma/Delisting↓(URGENT)👁
Critical bearish event, monitor transfer details and liquidity impact immediate Jan 2026
Item 2.02 results, watch for QoQ trends/oil volumes, likely call within 48hrs post-filing
Disclosure may precede guidance, track AGM/earnings Q1 2026 for industrial outlook
Item 5.02 change, monitor insider holdings post-change for conviction
Cluster of 1.01 deals (mat 7-8/10), exhibits for terms/valuations by Jan 30
Item 3.02 sales, watch share volume and price reaction for overhang
High 7/10 mat earnings, pending metrics for YoY silver output vs peers
- All 25 Earnings Filers (e.g. MainStreet, Bank of Marin)👁
No quant data, monitor transcripts for margin/NIM trends Q4 2025
Filing Analyses(55)
26-01-2026
Artificial Intelligence Technology Solutions Inc. filed an 8-K on January 26, 2026 (AccNo: 0001062993-26-000417), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financials, or exhibits are provided in the filing summary. Sector not specified.
26-01-2026
Baker Hughes Co filed an 8-K on 2026-01-26 (AccNo: 0001701605-26-000003, size 1 MB) reporting results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a financial results disclosure for the US market. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.
26-01-2026
FinTrade Sherpa, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001199835-26-000037) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, share counts, or other quantitative data disclosed in the provided summary. Sector is not specified.
26-01-2026
Orgenesis Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003501, Size: 331 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on the agreement, sales, transaction values, parties, or financial impacts. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
26-01-2026
STANLEY BLACK & DECKER, INC. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-021636, Size: 226 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason, or compensatory arrangements are provided in the filing summary. Sector not specified.
26-01-2026
Legato Merger Corp. IV filed an 8-K on 2026-01-26 (AccNo: 0001829126-26-000540, Size: 1 MB) disclosing entry into a Material Definitive Agreement under Item 1.01, related to a Merger/Acquisition event. Item 9.01 includes Financial Statements and Exhibits. No specific details on parties, deal structure, valuation, or other terms are disclosed.
26-01-2026
Eaton Corp plc filed a Form 8-K on January 26, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, named entities, or scheduled events are explicitly stated in the provided filing summary.
26-01-2026
Hecla Mining Co/DE/ filed a Form 8-K on January 26, 2026 (AccNo: 0001437749-26-002003), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific numerical data, transaction values, guidance, or scheduled events are mentioned in the provided filing summary.
26-01-2026
Cboe Global Markets, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001104659-26-006416, Size: 358 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected officer position, appointment or resignation, reasons, or quantitative data are provided. Sector not specified.
26-01-2026
BioMarin Pharmaceutical Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021718, Size: 573 KB), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction details, or quantitative data are mentioned.
26-01-2026
Armata Pharmaceuticals, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001104659-26-006446) reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, financial impacts, or other specifics are disclosed in the provided filing summary. This is a multi-item mandatory filing as a material event.
26-01-2026
Citizens Community Bancorp Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001367859-26-000005, Size: 12 MB) disclosing Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a financial results announcement from the US market, sector not specified. No specific financial metrics, transaction values, or other numerical data are mentioned.
26-01-2026
Traws Pharma, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001104659-26-006460, Size: 226 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
26-01-2026
Bank of Marin Bancorp filed an 8-K on 2026-01-26 (AccNo: 0001403475-26-000006, Size: 8 MB) reporting Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction details, or scheduled events are mentioned.
26-01-2026
Fifth Third Bancorp filed a Form 8-K on January 26, 2026 (AccNo: 0000035527-26-000017, Size: 2 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial impacts, or exhibits are provided in the filing summary. Sector not specified.
26-01-2026
XCF Global, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003538, Size: 417 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction value, share counts, counterparties, financial impacts, or strategic context provided in the summary. Sector is not specified.
26-01-2026
DevvStream Corp. filed a Form 8-K on 2026-01-26 (AccNo: 0001140361-26-002310, Size: 324 KB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for a material event. No transaction details, financial metrics, entities, or scheduled events are disclosed in the provided information.
26-01-2026
Crinetics Pharmaceuticals, Inc. filed an 8-K on 2026-01-26 (AccNo: 0001658247-26-000003, Size: 139 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. Specific details including the key position affected, appointment or resignation status, reasons, names, or any quantitative data are NOT_DISCLOSED. No scheduled events or financial metrics mentioned.
26-01-2026
Bank of Hawaii Corp filed an 8-K on January 26, 2026 (AccNo: 0000046195-26-000004, Size: 7 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results announcement with no specific revenue, earnings, or other quantitative metrics disclosed in the provided information. Sector is not specified.
26-01-2026
Paychex Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021794, Size: 5 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 1.02 termination of a material definitive agreement, and Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, counterparties, or financial impacts provided in the summary. Sector is not specified.
26-01-2026
Milestone Pharmaceuticals Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001104659-26-006483, Size: 240 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial impacts, or exhibits are disclosed in the provided filing summary. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
26-01-2026
Trade Desk, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-021804, Size: 169 KB) reporting an Officer Change under Item 5.02, alongside Results of Operations and Financial Condition (Item 2.02), Regulation FD Disclosure (Item 7.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the officer position, appointment or resignation, reasons, or quantitative financial metrics are explicitly stated in the provided filing summary.
26-01-2026
Peoples Bancorp of North Carolina Inc filed an 8-K on 2026-01-26 reporting Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction values, or other quantitative data are disclosed in the provided filing summary. This appears to be a standard voluntary disclosure of financial results.
26-01-2026
Horizon Bancorp Inc /IN/ filed a Form 8-K on January 26, 2026 (AccNo: 0000706129-26-000011), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the officer position, name, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Event type is Officer Change; sector not specified.
26-01-2026
Black Spade Acquisition III Co filed an 8-K on January 26, 2026 (AccNo: 0001104659-26-006523, Size: 29 KB) announcing a Merger/Acquisition event under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties involved, valuation, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.
26-01-2026
Oak Valley Bancorp filed an 8-K on 2026-01-26 (AccNo: 0001437749-26-002038, Size: 435 KB) disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or quantitative data are mentioned.
26-01-2026
Global Interactive Technologies, Inc. filed an 8-K on January 26, 2026 (AccNo: 0001493152-26-003585), reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts provided. Sector not specified.
26-01-2026
Peoples Bancorp Inc filed an 8-K on 2026-01-26 (AccNo: 0000318300-26-000034) disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No quantitative financial metrics, transaction values, or other numerical data are mentioned in the provided filing summary. This is a standard financial results announcement with no additional details on impacts or events.
26-01-2026
AgEagle Aerial Systems Inc. filed a Form 8-K on January 26, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This discloses the results of a shareholder vote, but no specific matters, outcomes, or numerical details are provided in the filing summary. The filing is a single-item mandatory disclosure under SEC rules.
26-01-2026
Capital Bancorp Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001419536-26-000006, size: 6 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, dollar values, percentages, or scheduled events are mentioned in the provided filing summary. This is a multi-item voluntary or mandatory disclosure depending on the underlying events, typically filed for earnings releases.
26-01-2026
Global Medical REIT Inc. disclosed an officer change via Form 8-K filed on January 26, 2026 (AccNo: 0001104659-26-006609, Size: 245 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, appointment/resignation status, reasons, or quantitative data are provided in the summary. Sector is not specified.
26-01-2026
GEO Group Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-022602, Size: 306 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or obligation under an off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, counterparties, or terms disclosed in the provided summary. All quantitative metrics, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
26-01-2026
Grayscale CoinDesk Crypto 5 ETF filed a Form 8-K on January 26, 2026, under Item 8.01 Other Events. Accession Number: 0001193125-26-022593, file size 177 KB. No specific details on the event, transaction values, or financial impacts disclosed in the provided filing summary.
26-01-2026
Triumph Financial, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001539638-26-000004, Size: 2 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
26-01-2026
Adeia Inc. disclosed an officer change via Form 8-K filed on January 26, 2026 (AccNo: 0001193125-26-022581, Size: 255 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or quantitative data are explicitly stated. Sector not specified.
26-01-2026
Mirum Pharmaceuticals, Inc. filed an 8-K on January 26, 2026 (AccNo: 0001193125-26-022582), announcing completion of an acquisition or disposition of assets (Item 2.01), Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details including parties involved, deal structure, valuation, strategic rationale, and shareholder impacts are NOT_DISCLOSED. Analysis is limited due to absence of explicit transaction data in the provided filing summary.
26-01-2026
Grayscale Dogecoin Trust ETF filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-022619, Size: 164 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impact, or scheduled events are disclosed in the provided filing summary. Sector not specified.
26-01-2026
FIRSTSUN CAPITAL BANCORP filed a Form 8-K on 2026-01-26 (AccNo: 0001709442-26-000004, Size: 7 MB) disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). The event is classified as an Officer Change in the US market, sector not specified. No specific details on officers, reasons for change, financial metrics, or scheduled events are provided.
26-01-2026
Liminatus Pharma, Inc. filed an 8-K on 2026-01-26 (AccNo: 0001104659-26-006619, Size: 241 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on the delisting reason, transaction value, financial impacts, or strategic context are disclosed. Sector is not specified.
26-01-2026
NBT Bancorp Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001140361-26-002399), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. Event type is Officer Change; sector not specified. No specific details on positions affected, individuals involved, reasons, financial metrics, or quantitative data are disclosed.
26-01-2026
SPLASH BEVERAGE GROUP, INC. filed a Form 8-K on 2026-01-26 (AccNo: 0001731122-26-000123) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, dollar values, share counts, or financial impacts disclosed in the provided summary. All quantitative and qualitative details on the events are NOT_DISCLOSED.
26-01-2026
SEMrush Holdings, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001628280-26-003416, size: 227 KB), reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impact, or scheduled events are disclosed in the provided filing summary. Sector not specified.
26-01-2026
LINKBANCORP, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-022725), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific numerical data, transaction details, or scheduled events are mentioned.
26-01-2026
German American Bancorp, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0000714395-26-000003, Size: 896 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a financial results announcement from the US market. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary.
26-01-2026
HOME BANCORP, INC. filed an 8-K on January 26, 2026 (AccNo: 0001628280-26-003427, Size: 7 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.
26-01-2026
Commercial Bancgroup, Inc. filed an 8-K on 2026-01-26 (AccNo: 0001213900-26-007744) reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific numerical data, metrics, or details provided in the filing summary. Sector not specified.
26-01-2026
Customers Bancorp, Inc. filed an 8-K on January 26, 2026 (AccNo: 0001488813-26-000015, Size: 4 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector is not specified.
26-01-2026
Delek Logistics Partners, LP filed a Form 8-K on January 26, 2026 (AccNo: 0001628280-26-003429, Size: 393 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with sector not specified. No specific details on events, transactions, financials, or exhibits are disclosed.
26-01-2026
ALPHA MODUS HOLDINGS, INC. filed a Form 8-K on January 26, 2026 (AccNo: 0001493152-26-003623), reporting Item 3.02 Unregistered Sales of Equity Securities and Item 8.01 Other Events. No specific details on the unregistered sales, other events, transaction values, share counts, or involved parties are disclosed. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
26-01-2026
NKGen Biotech, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001213900-26-007794, Size: 285 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, transaction value, counterparties, or financial impacts disclosed in the provided summary. Sector is NOT_DISCLOSED.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 55 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC